- Home
- BBIO vs ELS Comparison
BBIO vs ELS Comparison
Compare BBIO & ELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | ELS |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 12.8B |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BBIO | ELS |
|---|---|---|
| Price | $85.26 | $66.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 10 |
| Target Price | ★ $86.33 | $70.25 |
| AVG Volume (30 Days) | ★ 3.3M | 1.5M |
| Earning Date | 05-12-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.49% |
| EPS Growth | N/A | ★ 2.55 |
| EPS | N/A | ★ 0.56 |
| Revenue | $502,076,000.00 | ★ $1,531,382,000.00 |
| Revenue This Year | $89.45 | $3.97 |
| Revenue Next Year | $73.78 | $4.69 |
| P/E Ratio | ★ N/A | $116.16 |
| Revenue Growth | ★ 126.26 | 0.34 |
| 52 Week Low | $42.09 | $57.63 |
| 52 Week High | $93.42 | $69.00 |
Technical Indicators
Market Signals| Indicator | BBIO | ELS |
|---|---|---|
| Relative Strength Index (RSI) | 66.40 | 58.74 |
| Support Level | $62.93 | $61.39 |
| Resistance Level | $93.42 | $68.73 |
| Average True Range (ATR) | 3.35 | 1.34 |
| MACD | -0.14 | 0.08 |
| Stochastic Oscillator | 42.05 | 85.05 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company has a portfolio of 453 properties across the US with a higher concentration in the Sun Belt; 38% of its properties are in Florida, 11% in Arizona, and 10% in California. Equity Lifestyle targets owning properties in attractive retirement destinations. More than 70% of the company's properties are either age-restricted or have an average resident age over 55.